Specialized cGMP Cleanroom Framework for Viral Vector Biomanufacturing
We deliver high-standard cGMP-compliant cleanroom design and construction solutions purpose-built for viral vector production, including AAV, lentivirus, adenovirus, and retrovirus manufacturing for cell and gene therapy workflows. Viral vector production features high biological risk, sensitive microbial control requirements, and strict segregated operation protocols that differ significantly from conventional biopharmaceutical processes. Our cleanroom architecture is fully optimized for upstream cell transfection, viral packaging, vector harvesting, downstream purification, and sterile fill-finish, providing a biosafety-level, contamination-free core environment for stable and reproducible viral vector batch manufacturing.
Biosafety-Oriented Zoning & Segregated Process Flow Design
Our cleanroom layout adopts rigorous functional partitioning, unidirectional personnel and material flow, and independent contaminated area isolation to address the unique biosafety demands of viral vector processing. We implement graded cleanroom classification, precise differential pressure cascades, and dedicated airlock systems to completely separate clean zones, semi-contaminated zones and viral active operation zones. Independent exhaust treatment, dedicated waste disposal pipelines and isolated HVAC airflow systems effectively prevent cross-contamination and viral aerosol diffusion. The streamlined process layout minimizes human intervention and material cross-over, ensuring superior environmental purity and operational safety for complex vector production procedures.
Full-Parameter Environmental Control & Regulatory Compliance Assurance
All cleanroom structural designs, surface material selection, airflow organization, and environmental monitoring systems strictly comply with FDA, EMA and global cGMP guidelines for advanced therapy medicinal products (ATMPs). We deploy high-efficiency filtration systems, stable temperature and humidity regulation, real-time particle and bioburden monitoring, and full-data traceability platforms to maintain continuous environmental qualification. Our team provides complete DQ, IQ, OQ and PQ validation packages and standardized GMP documentation, ensuring full lifecycle compliance, audit readiness, and seamless regulatory approval for viral vector production facilities.
Modular & Future-Proof Design for Gene Therapy Industrialization
Engineered for both clinical trial batch manufacturing and large-scale commercial production, our viral vector cleanroom solutions integrate modular construction, scalable spatial planning and flexible process compatibility. The design reserves expansion capacity for multi-vector pipeline production, process optimization and capacity scale-up to adapt to fast iteration trends in gene therapy development. By balancing stringent biosafety compliance, operational stability and long-term cost efficiency, we deliver fully qualified, sustainable and industry-leading cGMP cleanroom infrastructures to accelerate clients’ clinical transformation and commercialization of viral vector-based therapeutics.
